NCT06131970 (KONTINUE) is a clinical trial in Chronic Pain, sponsored by Centre Hospitalier Princesse Grace.

Who is sponsoring NCT06131970?

NCT06131970 is sponsored by Centre Hospitalier Princesse Grace.

What condition does NCT06131970 study?

NCT06131970 studies Chronic Pain.

Is NCT06131970 still recruiting?

NCT06131970 is currently completed. Last updated 19 February 2025.

Last reviewed 2025-02-19 · How we verify

NCT06131970: KONTINUE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Continuous Ketamine Infusion (KONTINUE)

Completed Last updated 19 February 2025

What this trial tests

trial in Chronic Pain in 80 participants. Completed in 6 August 2024.

Timeline

22 February 2022

Primary endpoint
6 August 2024

6 August 2024

Quick facts

Lead sponsor	Centre Hospitalier Princesse Grace
Status	Completed
Study type	OBSERVATIONAL
Enrollment	80
Start date	22 February 2022
Primary completion	6 August 2024
Estimated completion	6 August 2024
Sites	1 location across Monaco

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Centre Hospitalier Princesse Grace

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There are different treatment for chronic pain. One possible treatment is intravenous infusions of ketamine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Centre Hospitalier Princesse Grace trials

Trials by the same sponsor.

NCT05885529 — Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin Carboxy-terminal Hydrolase L1 (UCH-L1) to Exclude Lesions Linked to · recruiting
NCT05779865 — Study of Different Gating Techniques for PET Image of Lung and Liver Lesions · completed
NCT04437927 — Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT · completed
NCT04418193 — Patient Preference Trial for COVID-19 (PPT-COVID) · withdrawn
NCT04441489 — Assessment of Lung Inflammation With FDG PET/CT in COVID-19 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06131970 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Princesse Grace
Last refreshed: 19 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06131970.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing